INTRODUCTION
Acute generalized exanthematous pustulosis (AGEP), a self-limiting drug eruption, commonly occur secondary to antibiotics. We present a first case of AGEP after treatment with daptomycin, an antibiotic used to treat infections caused by methicillin-resistant Staphylococcus aureus, penicillin-resistant streptococci and vancomycin-resistant enterococci.
CASE REPORT
A 57-year-old man, with underlying problems of hypertension and poorly controlled diabetes mellitus, was admitted for right foot osteomyelitis with septic shock. He had no history of skin disease. He underwent a right below-knee amputation and was post-operatively started on vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia. However, due to poor clinical response and persistently high vancomycin minimum inhibitory concentration levels, vancomycin was switched to intravenous daptomycin. On day 24 of daptomycin administration, the patient developed a non-pruritic generalised maculopapular erythematous rash over the trunk and limbs, with no mucosal involvement. He had a temperature of 38.6 o C, leucocytosis of 17.6×10 9 /L, and an absolute neutrophil count of 8.4×10 3 /μl. Skin scraping for fungal microscopy was negative. Six days later, the rash became more extensive with small pit-point pustules and superficial scaling. A skin biopsy ( Fig. 1 AGEP resolves upon discontinuation of the implicated medication, which may be the only required therapeutic measure. Some patients may require topical corticosteroids to help alleviate symptoms. Our patient had clinical and histological findings consistent with AGEP. In view of the timing of onset and resolution of the rash with regards to the course of daptomycin, and after exclusion of other causative drugs, our patient most likely had AGEP secondary to daptomycin. To the best of our knowledge, this is the first report of AGEP caused by daptomycin.
